1Cooper, D, Limet, N, McClung, I, Lawrie, SM. Towards clinically useful neuroimaging in psychiatric practice. Br J Psychiatry 2013; 203: 242–4.
2Robinson, L, Sprooten, E, Lawrie, SM. Brain imaging in psychosis and psychopathy–ethical considerations. Cortex 2011; 47: 1236–9.
3Lawrie, SM, Stanfield, A, Johnstone, EC, McIntosh, AM. Predicting first episode psychosis in those at high risk for genetic or cognitive reasons. Epidemiol Psychiatr Sci 2012; 21: 323–8.
4Bernardini, F, Attademo, L, Cleary, SD, Luther, C, Shim, RS, Quartesan, R, et al. Risk prediction models in psychiatry: toward a new frontier for the prevention of mental illnesses. J Clin Psychiatry 2017; 78: 572–83.
5Whalley, HC, Sussmann, JE, Romaniuk, L, Stewart, T, Papmeyer, M, Sprooten, E, et al. Prediction of depression in individuals at high familial risk of mood disorders using functional magnetic resonance imaging. PLoS One 2013; 8: e57357.
6Schmidt, A, Cappucciati, M, Radua, J, Rutigliano, G, Rocchetti, M, Dell'Osso, L, et al. Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation. Schizophr Bull 2017; 43: 375–88.
7Hunter, SA, Lawrie, SM. Imaging and genetic biomarkers predicting transition to psychosis. Curr Top Behav Neurosci 2018; 40: 353–88.
8Cannon, TD, Yu, C, Addington, J, Bearden, CE, Cadenhead, KS, Cornblatt, BA, et al. An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry 2016; 173: 980–8.
9Zarogianni, E, Storkey, AJ, Johnstone, EC, Owens, DG, Lawrie, SM. Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features. Schizophr Res 2017; 181: 6–12.
10Lawrie, SM. Clinical risk prediction in schizophrenia. Lancet Psychiatry 2014; 1: 406–8.
11Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–7.
12Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 2018; 50: 668–81.
13Agerbo, E, Sullivan, PF, Vilhjálmsson, BJ, Pedersen, CB, Mors, O, Børglum, AD, et al. Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia: a Danish population-based study and meta-analysis. JAMA Psychiatry 2015; 72: 635–41.
14Neilson, E, Bois, C, Clarke, TK, Hall, L, Johnstone, EC, Owens, DGC, et al. Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study. Psychol Med 2018; 48: 1532–9.
15Lawrie, SM, Olabi, B, Hall, J, McIntosh, AM. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry 2011; 10: 19–31.
16Alladi C, G, Etain, B, Bellivier, F, Marie-Claire, C. DNA methylation as a biomarker of treatment response variability in serious mental illnesses: a systematic review focused on bipolar disorder, schizophrenia, and major depressive disorder. Int J Mol Sci 2018; 19: E3026.
17Fond, G, d'Albis, MA, Jamain, S, Tamouza, R, Arango, C, Fleischhacker, WW, et al. The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull 2015; 41: 559–73.
18Marwood, L, Wise, T, Perkins, AM, Cleare, AJ. Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95: 61–72.
19Lee, Y, Ragguett, RM, Mansur, RB, Boutilier, JJ, Rosenblat, JD, Trevizol, A, et al. Applications of machine learning algorithms to predict therapeutic outcomes in depression: a meta-analysis and systematic review. J Affect Disord 2018; 241: 519–32.
20Drysdale, AT, Grosenick, L, Downar, J, Dunlop, K, Mansouri, F, Meng, Y, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23: 28–38.
21McGinn, TG, Guyatt, GH, Wyer, PC, et al. Users’ guides to the medical literature, XXII: how to use articles about clinical decision rules. JAMA 2000; 284: 79–84.
22Dluhoš, P, Schwarz, D, Cahn, W, van Haren, N, Kahn, R, Španiel, F, et al. Multi-center machine learning in imaging psychiatry: a meta-model approach. Neuroimage 2017; 155: 10–24.
23Thompson, PM, Stein, JL, Medland, SE, Hibar, DP, Vasquez, AA, Renteria, ME. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014; 8: 153–82.
24Rose, D, Papoulias, C, MacCabe, J, Walke, J. Service users’ and carers’ views on research towards stratified medicine in psychiatry: a qualitative study. BMC Res Notes 2015; 8: 489.
25Fisher, AJ, Medaglia, JD, Jeronimus, BF. Lack of group-to-individual generalizability is a threat to human subjects research. Proc Natl Acad Sci U S A 2018; 115: E6106–15.
26Johnstone, M, Vasistha, NA, Barbu, MC, Dando, O, Burr, K, Christopher, E, et al. Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imaging. Mol Psychiatry 2019; 24: 294–311.
27Fusar-Poli, P, McGorry, PD, Kane, JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry 2017; 16: 251–65.
28Correll, CU, Galling, B, Pawar, A, Krivko, A, Bonetto, C, Ruggeri, M, et al. Comparison of early intervention studies vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis and meta-regression. JAMA Psychiatry 2018; 75: 555–65.
29McHugh, RK, Whitton, SW, Peckham, AD, Welge, JA, Otto, MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013; 74: 595–602.
30Doyle, OM, Bois, C, Thomson, P, Romaniuk, L, Whitcher, B, Williams, SC, et al. The cortical thickness phenotype of individuals with DISC1 translocation resembles schizophrenia. J Clin Invest 2015; 125: 3714–22.
31Yehuda, R, Lehrner, A. Intergenerational transmission of trauma effects: putative role of epigenetic mechanisms. World Psychiatry 2018; 17: 243–57.